We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Directly Differentiated Neurons Maintain Precursor Cells' Genetic Aging Pattern

By LabMedica International staff writers
Posted on 21 Oct 2015
Advanced stem cell techniques allow direct inducement of neurons that maintain the genetic pattern of aging that was present in the precursor skin fibroblasts and which may be used to model age-related neurological diseases.

Investigators at the Salk Institute for Biological Studies (La Jolla, CA, USA) generated neurons from skin fibroblasts obtained from 19 human donors aged from birth to 89 years either by iPSC (induced pluripotent stem cell)-based reprogramming and differentiation or by direct conversion into induced neurons (iNs). More...


Neurons derived by the iPSC method did not retain aging-associated gene signatures. On the other hand, use of non-viral plasmid transfection or protein transduction allowed the generation of induced neural precursor (iNP) colonies expressing a range of neural stem and pro-neural genes. Upon differentiation, iNP cells gave rise to neurons (iNs) exhibiting typical neuronal morphologies and expressing multiple neuronal markers including tyrosine hydroxylase and GAD65/67. Importantly, iNP-derived neurons demonstrated electrophysiological properties of functionally mature neurons with the capacity to generate action potentials. In addition, iNP cells were capable of differentiating into glial fibrillary acidic protein (GFAP)-expressing astrocytes.

The investigators reported in the October 8, 2015, issue of the journal Cell Stem Cell that while iPSCs and their derived neurons did not retain aging-associated gene signatures, iNs displayed age-specific transcriptional profiles and revealed age-associated decreases in the nuclear transport receptor RanBP17. They detected an age-dependent loss of nucleocytoplasmic compartmentalization (NCC) in donor fibroblasts and corresponding iNs and found that reduced RanBP17 impaired NCC in young cells, while iPSC rejuvenation restored NCC in aged cells.

"The neurons we derived showed differences depending on donor age,” said first author Dr. Jerome Mertens, a postdoctoral researcher at the Salk Institute for Biological Studies. "And they actually show changes in gene expression that have been previously implicated in brain aging. For instance, levels of a nuclear pore protein called RanBP17—whose decline is linked to nuclear transport defects that play a role in neurodegenerative diseases—were lower in the neurons derived from older patients."

Related Links:

Salk Institute for Biological Studies



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.